About TETRALOGIC PHARMACEUTICALS CORP
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TLOG is 0.000100 USD — it has increased by 9.90 K% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange TETRALOGIC PHARMACEUTICALS CORP stocks are traded under the ticker TLOG.
TETRALOGIC PHARMACEUTICALS CORP is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
TLOG stock is 99.00% volatile and has beta coefficient of 0. Check out the list of the most volatile stocks — is TETRALOGIC PHARMACEUTICALS CORP there?
Yes, you can track TETRALOGIC PHARMACEUTICALS CORP financials in yearly and quarterly reports right on TradingView.
No, TLOG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TLOG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TETRALOGIC PHARMACEUTICALS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TETRALOGIC PHARMACEUTICALS CORP technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TETRALOGIC PHARMACEUTICALS CORP stock shows the sell signal. See more of TETRALOGIC PHARMACEUTICALS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.